Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review. | Proteomes | 2024 | 38250814 | PubTator, text mining | PubMed |
| Molecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes. | Curr Issues Mol Biol | 2024 | 38248332 | PubTator, text mining | PubMed |
| Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19. | J Clin Immunol | 2024 | 38231281 | PubTator, text mining | PubMed |
| Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma. | BMC Med | 2024 | 38229080 | PubTator, text mining | PubMed |
| Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study. | Sci Rep | 2024 | 38228698 | PubTator, text mining | PubMed |
| Identification of pattern recognition receptor genes in peripheral blood mononuclear cells and monocytes as biomarkers for the diagnosis of lupus nephritis. | Clin Chim Acta | 2024 | 38228224 | PubTator, text mining | PubMed |
| The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma. | Open Med (Wars) | 2024 | 38221934 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies. | Cell Death Discov | 2024 | 38218941 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation. | Cell Commun Signal | 2024 | 38195584 | PubTator, text mining | PubMed |
| LNCGM1082 in Gut Epithelial Cells Promotes Expulsion of Infected Epithelial Cells and Release of IL-18. | Immunohorizons | 2024 | 38189743 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in central nervous system (CNS) diseases. | PeerJ | 2024 | 38188146 | PubTator, text mining | PubMed |
| The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA. | Pediatr Rheumatol Online J | 2024 | 38183098 | PubTator, text mining | PubMed |
| Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. | Pediatr Rheumatol Online J | 2024 | 38183096 | PubTator, text mining | PubMed |
| Mechanisms and effects of NLRP3 in digestive cancers. | Cell Death Discov | 2024 | 38182564 | PubTator, text mining | PubMed |
| Structural basis of the human NAIP/NLRC4 inflammasome assembly and pathogen sensing. | Nat Struct Mol Biol | 2024 | 38177670 | PubTator, text mining | PubMed |
| The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica. | Sci Rep | 2024 | 38177227 | PubTator, text mining | PubMed |
| The role of inflammasomes in human diseases and their potential as therapeutic targets. | Signal Transduct Target Ther | 2024 | 38177104 | PubTator, text mining | PubMed |
| Guarea microcarpa C. DC. extract inhibits NLRP3 inflammasome by suppressing its ATPase activity. | J Ethnopharmacol | 2024 | 38176663 | PubTator, text mining | PubMed |
| Identification of the role of pyroptosis-related genes in chronic rhinosinusitis based on WGCNA. | Heliyon | 2024 | 38173477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=11